| scholarly article | Q13442814 |
| P2093 | author name string | J. C. Jennette | |
| R. J. Falk | |||
| M. Becker | |||
| R. Terrell | |||
| P2860 | cites work | Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase | Q24339350 |
| Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme | Q24683141 | ||
| Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis | Q27478432 | ||
| Wegener's autoantigen decoded | Q28292951 | ||
| Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis | Q29619713 | ||
| Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis | Q29619714 | ||
| Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro | Q33605284 | ||
| Monoclonal antibodies to the apical chloride channel in Necturus gallbladder inhibit the chloride conductance | Q34309464 | ||
| Myeloperoxidase-mediated iodination by granulocytes. Intracellular site of operation and some regulating factors | Q34516642 | ||
| Epitopes on protein antigens: misconceptions and realities. | Q36576238 | ||
| Antineutrophil cytoplasmic autoantibodies and associated diseases: a review | Q37592578 | ||
| Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis | Q37873413 | ||
| ANCA-associated renal disease | Q38016180 | ||
| The antigenic structure of proteins: a reappraisal. | Q40076398 | ||
| Termination of the Respiratory Burst in Human Neutrophils | Q40152532 | ||
| Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils | Q40380323 | ||
| Analysis of the peptide subunits of human neutrophil myeloperoxidase | Q42054401 | ||
| Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. | Q55054841 | ||
| Iodination by human polymorphonuclear leukocytes: a re-evaluation | Q67550441 | ||
| Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network | Q68574270 | ||
| Reactivity of anti-neutrophil cytoplasmic autoantibodies with HL-60 cells | Q69356860 | ||
| Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis | Q69509316 | ||
| Association between active Wegener's granulomatosis and anticytoplasmic antibodies | Q69554001 | ||
| Isolation and properties of human neutrophil myeloperoxidase | Q72881740 | ||
| The reductive cleavage of myeloperoxidase in half, producing enzymically active hemi-myeloperoxidase | Q72887450 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autoantibody | Q785022 |
| P304 | page(s) | 274-278 | |
| P577 | publication date | 1992-08-01 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | Anti-myeloperoxidase autoantibodies react with native but not denatured myeloperoxidase | |
| P478 | volume | 89 |
| Q35546154 | A case of a false-positive anti-myeloperoxidase antibody ELISA in a patient with hypothyroidism |
| Q77953533 | A comparison of the characteristics of circulating anti-myeloperoxidase autoantibodies in vasculitis with those in non-vasculitic conditions |
| Q74419132 | A panel set for epitope analysis of myeloperoxidase (MPO)-specific antineutrophil cytoplasmic antibody MPO-ANCA using recombinant hexamer histidine-tagged MPO deletion mutants |
| Q48669544 | A specific method for measurement of equine active myeloperoxidase in biological samples and in in vitro tests |
| Q98778531 | ANCA-associated vasculitis |
| Q53793455 | Analysis of immunoglobulin variable region genes of a human IgM anti-myeloperoxidase antibody derived from a patient with vasculitis. |
| Q33566028 | Anti-myeloperoxidase antibodies in patients with rheumatoid arthritis: prevalence, clinical correlates, and IgG subclass |
| Q45063512 | Anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis might recognize restricted epitopes on myeloperoxidase molecule |
| Q40636649 | Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential |
| Q33915352 | Antineutrophil cytoplasmic antibodies (ANCA) and systemic vasculitis: update of assays, immunopathogenesis, controversies, and report of a novel de novo ANCA-associated vasculitis after kidney transplantation |
| Q47702487 | Antineutrophil cytoplasmic antibodies in patients with Graves' disease: association of antimyeloperoxidase autoantibodies with propylthiouracil therapy |
| Q37051208 | Antineutrophil cytoplasmic autoantibodies: how should the biologist manage them? |
| Q34449107 | Are antineutrophil cytoplasmic antibodies pathogenic? Experimental approaches to understand the antineutrophil cytoplasmic antibody phenomenon |
| Q84675165 | Autoantibodies in ANCA-associated Vasculitis |
| Q36436250 | Autoantibodies to intracellular autoantigens and their B-cell epitopes: molecular probes to study the autoimmune response. |
| Q35867513 | B cell epitope specificity in ANCA-associated vasculitis: does it matter? |
| Q37592015 | Clinical and pathophysiological significance of anti-neutrophil cytoplasmic autoantibodies in vasculitis syndromes |
| Q34449099 | Clinical use of serological tests for antineutrophil cytoplasmic antibodies. What do the studies say? |
| Q53263507 | Comparison of characteristics of natural autoantibodies against myeloperoxidase and anti-myeloperoxidase autoantibodies from patients with microscopic polyangiitis. |
| Q37691257 | Epitope analysis of anti-myeloperoxidase antibodies in propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis |
| Q27473530 | Epitope mapping of anti-proteinase 3 and anti-myeloperoxidase antibodies |
| Q46385854 | IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis |
| Q82929896 | Mapping of myeloperoxidase epitopes recognized by MPO-ANCA using human-mouse MPO chimers |
| Q34395155 | Methods for the detection of anti-neutrophil cytoplasmic antibodies. Recommendations for clinical use of ANCA serology and laboratory efforts to optimize the informative value of ANCA test results |
| Q34397155 | Neutrophil functions of patients with vasculitis related to myeloperoxidase-specific anti-neutrophil antibody |
| Q33843581 | Pathogenesis of ANCA-associated systemic vasculitis |
| Q71878208 | Significance of myeloperoxidase in rapidly progressive glomerulonephritis |
| Q71627913 | Some patients with anti-myeloperoxidase autoantibodies have a C-ANCA pattern |
| Q73875910 | Studies of epitope restriction on myeloperoxidase (MPO), an important antigen in systemic vasculitis |
| Q27473538 | The diversity of perinuclear antineutrophil cytoplasmic antibodies (pANCA) antigens |
Search more.